Your browser doesn't support javascript.
loading
An Implementation Trial to Improve Tobacco Treatment for Cancer Patients: Patient Preferences, Treatment Acceptability and Effectiveness.
LeLaurin, Jennifer H; Dallery, Jesse; Silver, Natalie L; Markham, Merry-Jennifer; Theis, Ryan P; Chetram, Deandra K; Staras, Stephanie A; Gurka, Matthew J; Warren, Graham W; Salloum, Ramzi G.
Afiliación
  • LeLaurin JH; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Dallery J; Department of Psychology, University of Florida, Gainesville, FL 32611, USA.
  • Silver NL; Department of Otolaryngology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Markham MJ; Division of Hematology/Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Theis RP; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Chetram DK; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Staras SA; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Gurka MJ; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Warren GW; Department of Cell and Molecular Pharmacology and Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA.
  • Salloum RG; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Int J Environ Res Public Health ; 17(7)2020 03 28.
Article en En | MEDLINE | ID: mdl-32231062
Continued smoking after a cancer diagnosis increases mortality, risk of recurrence, and negatively impacts treatment effectiveness. However, utilization of tobacco use cessation treatment among cancer patients remains low. We conducted a clinical trial assessing patient preferences, treatment acceptability, and preliminary effectiveness (7-day point prevalence at 12 weeks) of three tobacco treatment options among cancer patients at an academic health center. Implementation strategies included electronic referral and offering the choice of three treatment options: referral to external services, including the quitline (PhoneQuit) and in-person group counseling (GroupQuit), or an internal service consisting of 6-week cognitive behavioral therapy delivered via smartphone video conferencing by a tobacco treatment specialist (SmartQuit). Of 545 eligible patients, 90 (16.5%) agreed to enroll. Of the enrolled patients, 39 (43.3%) chose PhoneQuit, 37 (41.1%) SmartQuit, and 14 (15.6%) GroupQuit. Of patients reached for 12-week follow-up (n = 35), 19 (54.3%) reported receiving tobacco treatment. Of all patients referred, 3 (7.7%) PhoneQuit, 2 (5.4%) SmartQuit, and 2 (14.3%) GroupQuit patients reported 7-day point prevalence abstinence from smoking at 12 weeks. Participants rated the SmartQuit intervention highly in terms of treatment acceptability. Results indicate that more intensive interventions may be needed for this population, and opportunities remain for improving reach and utilization.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tabaquismo / Cese del Hábito de Fumar / Neoplasias Tipo de estudio: Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Environ Res Public Health Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tabaquismo / Cese del Hábito de Fumar / Neoplasias Tipo de estudio: Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Environ Res Public Health Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza